Beyond Blood Sugar: How Incretin Peptides Are Redefining Metabolic Health

April 9, 2025

Abstract Multifunctional incretin peptides are revolutionizing the treatment landscape for type 2 diabetes and obesity. Unlike traditional therapies that target a single metabolic pathway, these innovative peptides are designed to activate multiple receptors—such as GLP-1, GIP, and glucagon—delivering synergistic effects on blood glucose control, weight loss, and overall metabolic health. Dual agonists like tirzepatide have […]

From Diabetes to Liver Disease: The Expanding Role of GLP-1 Receptor Agonists

April 2, 2025

Abstract Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are revolutionizing the management of metabolic diseases, offering powerful benefits that extend far beyond glucose control. Originally developed for type 2 diabetes, GLP-1RAs have demonstrated significant advantages in promoting weight loss, reducing cardiovascular risk, and now, treating liver conditions such as metabolic dysfunction-associated steatohepatitis (MASH). Backed by robust clinical […]

Beyond Serelaxin: Engineering Durable RXFP1 Agonists for Next-Generation Cardiovascular and Renal Therapy

April 2, 2025

Abstract Relaxin-2, a hormone with well-documented roles in vascular and renal physiology, has demonstrated therapeutic potential in acute heart failure and renal dysfunction. However, the clinical utility of serelaxin, its recombinant form, is hindered by a short half-life and intravenous delivery requirements. R2R01, a novel single-chain peptide agonist of RXFP1, was developed to address these […]

From Bottlenecks to Breakthroughs: Redesigning Microbial Strains for Enhanced Peptide Production

March 28, 2025

Abstract Non-ribosomal peptides (NRPs) are a diverse class of bioactive compounds with immense pharmaceutical and industrial value. However, their biosynthesis is often limited by complex regulatory networks in native microbial hosts, hindering scalable production. This blog explores a recent study that introduces a rational, multi-target strategy to enhance NRP yield through genome-wide CRISPR interference (CRISPRi) […]

The Future of Immune Checkpoint Inhibition – Small Molecule and Peptide-Based Approaches

March 27, 2025

Abstract Immune checkpoint inhibitors have revolutionized cancer immunotherapy, yet monoclonal antibodies (mAbs) face limitations such as poor oral bioavailability, high immunogenicity, and restricted patient response rates. To address these challenges, small molecule and peptide-based checkpoint inhibitors have emerged as promising alternatives, offering enhanced tumor penetration, flexible pharmacokinetics, and lower production costs. Advances in high-throughput screening, […]

Cholecystokinin: A Multifunctional Peptide at the Intersection of Metabolism, Neuroscience, and Oncology

March 21, 2025

Abstract Cholecystokinin (CCK) is a multifunctional peptide that plays a pivotal role in gastrointestinal regulation, neuroendocrine signaling, metabolic homeostasis, and oncogenesis. Initially identified as a digestive hormone, CCK has since been recognized as a key neuromodulator and cytokine-like peptide with diverse physiological effects. Its bioactivity is mediated through CCK1 and CCK2 receptors, which regulate digestion, […]

Peptide-Based Immune Checkpoint Inhibitors: The Next Frontier in Cancer Immunotherapy

March 19, 2025

Abstract Peptide-based immune checkpoint inhibitors (ICIs) are emerging as a promising alternative to monoclonal antibodies and small-molecule inhibitors in cancer immunotherapy. These peptides effectively disrupt immune checkpoint interactions, such as PD-1/PD-L1, TIGIT/PVR, and LAG-3/MHC-II, to restore antitumor immune responses. Recent advancements in peptide engineering, including cyclization, D-amino acid incorporation, and peptide-drug conjugates (PDCs), have improved […]

Legume-Derived Bioactive Peptides: A Natural Approach to Cardiovascular Disease Prevention and Therapy

March 18, 2025

Abstract Cardiovascular diseases (CVDs) remain a leading cause of mortality worldwide, necessitating alternative strategies for prevention and management. Bioactive peptides derived from legumes have emerged as promising natural agents due to their ability to regulate blood pressure, improve endothelial function, and modulate lipid metabolism. These peptides exert cardioprotective effects by inhibiting angiotensin-converting enzyme (ACE), enhancing […]

TXM Peptides: A Promising Antiviral and Anti-Inflammatory Therapeutic Strategy Against SARS-CoV-2

March 13, 2025

Abstract The SARS-CoV-2 pandemic continues to pose significant global health challenges, necessitating novel therapeutic approaches beyond vaccines and traditional antivirals. Thioredoxin mimetic (TXM) peptides represent a promising dual-action strategy, targeting both viral entry and inflammatory pathways. These peptides disrupt disulfide bonds within the spike protein receptor-binding domain (RBD), weakening its interaction with ACE2 receptors and […]

Exploring the Role of Neuropeptides in Orofacial Pain: Implications for Future Treatments

March 13, 2025

Abstract Orofacial pain, a prevalent and often debilitating condition, involves complex mechanisms that remain inadequately addressed by current therapeutic options. Neuropeptides, small protein-like molecules involved in pain regulation, have emerged as key mediators in the development and modulation of orofacial pain. This review explores the roles of various neuropeptides, including Calcitonin Gene-Related Peptide (CGRP), Substance […]